|
|
Synthesis of N-(per)fluoroalkyl azoles by rhodium(II)-catalyzed transannulation of N-(per)fluoroalkyl-1,2,3-triazoles
Bakhanovich, Olga ; Beier, Petr (advisor) ; Kočovský, Pavel (referee) ; Kvíčala, Jaroslav (referee)
This Thesis deals with the synthesis of N-fluoroalkyl azoles via rhodium(II)-catalyzed transannulation of N-fluoroalkyl-1,2,3-triazoles obtained through copper(I)-catalyzed azide- alkyne cycloaddition (CuAAC) of N-fluoroalkyl azides and alkynes. The introductory chapter describes general approaches towards N-fluoroalkyl azoles, focusing on the synthesis of N-fluoroalkyl pyrroles and azoles. In the first part of the Thesis, rhodium(II)-catalyzed transannulation of N-fluoroalkyl-1,2,3- triazoles with terminal alkynes is described. The reaction provides access to N-fluoroalkyl pyrroles. The regioselectivity of the reaction is investigated and modifications of the primary product are suggested. In the second part of the Thesis, the reactivity of 4-cyclohexyl-N-fluoroalkyl-1,2,3-triazoles is investigated. A one-pot two-step reaction is presented, providing access to novel N- fluoroalkyl indoles. Several modification routes are suggested.
|
|
|
Design and synthesis of novel 3-aroyl-1-arylpyrrole derivatives as potential tubulin polymerization inhibitors
Zenkerová, Katharina ; Zitko, Jan (advisor) ; Kučerová, Marta (referee)
Charles University Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Pharmaceutical Analysis Author: Katharina Zenkerová Supervisors: Assoc. Prof. PharmD. Jan Zitko, Ph.D.; Prof. Romano Silvestri Title of diploma thesis: Design and synthesis of novel 3-aroyl-1-arylpyrrole derivatives as potential tubulin polymerization inhibitors Key word: anticancer agents; pyrrole; tubulin polymerization inhibitors Cancer is a major burden of disease worldwide and it remains one of the most difficult illnesses to treat. Since the percentage of people suffering from cancer is increasing, an enormous effort to design and develop better medicaments is needed. Microtubules are a key component of the cytoskeleton in most eukaryotic cells and they represent an attractive target for antitumor agents, due to the significant mitosis rate of tumor cells. Since cancer cells usually display higher proliferation rates than normal cells, drugs that interfere with microtubules dynamic equilibrium, also known as antimitotic agents, have become a fruitful approach to develop anticancer agents in clinical use. In fact, agents interfering with microtubules may either inhibit the tubulin polymerization or block microtubules to disassembly, both causing the arrest of cell division and the consequent...
|
guest ::
